RE: Great opportunity.26 Nov 2024 19:48
Commenting, Dr Dan Gooding, Executive Director of Nuformix, said: "The Fundraise will support the Company through an exciting period as we strive to reach a conclusion with a specialist development partner, who like us are keen to improve the treatment of IPF and PPF via inhalation. Inhalation is an untapped option in the industry's efforts to halt disease progression in what remains a poorly treated disease area with mortality greater than many cancers, and alleviate symptoms that dramatically impact patient quality of life. I look forward to providing further updates in due course."